What’s good about the SRO listing is there isn’t a negative comment or warning attached by the FDA. The continuing good information coming from Slashnuts supports GreenShifts positive position with the government. Although the board still has those who find rocks to sling theirs stones are getting scarce and small.
You're right, the fact that Greenshift is on this "well-regulated" list is very interesting, and it may offer us, the long-suffering GERS sharehholders, an opportunity to learn something more about this company.
If Kevin and the rest of the management team refuses to send the SEC the financial documents that would allow us to read them and make investment decisions that are based on them, then perhaps we can get some financial information about Greenshift from the U.S. Food and Drug Administration!